Search results
Showing 1336 to 1350 of 1374 results for patients and public
Antibiotics should not be issued as first line of treatment for a cough, says NICE and PHE
People should take honey or cough medicines instead but speak to their GP if it persists for longer than three weeks
Antibiotics should not be used to treat the majority of sinus infections, NICE says
NICE is advising healthcare professionals to tell their patients that a sinus infection will likely clear-up without antibiotics and that there is little evidence oral decongestants will help to relieve their symptoms.
NICE has produced a guide for commissioners on hip fracture services, which provides advice on commissioning services for people with fragility fracture of the hip or fracture of the hip due to osteoporosis or osteopenia.
A number of commonly used drug treatments for chronic primary pain have little or no evidence that they work and shouldn’t be prescribed, NICE has said in its draft clinical guideline published today (3 August 2020) on the assessment and management of chronic pain in over 16s.
Diagnose and treat Lyme disease if bull's eye rash is present, says NICE
People presenting erythema migrans, the characteristic skin rash associated with Lyme disease, can be diagnosed and treated without the need for blood tests, NICE has said in a final quality standard published today.
Health professionals can consider digital and mobile interventions as a supplement to regular services to support behaviour change in people at risk of developing chronic conditions.
A magnetic marker liquid injected into people with invasive breast cancer will help surgeons discover if the cancer has spread, after the technology was recommended in draft NICE guidance.
NICE has today (16 February 2023) issued draft guidance for public consultation which does not recommend Evusheld for preventing COVID-19 in adults who are unlikely to have an adequate immune response to COVID-19 vaccination, or who can’t be vaccinated.
NICE reaches important milestone in the UK's efforts to tackle antimicrobial resistance.
Two new antimicrobial drugs - cefiderocol and ceftazidime–avibactam - are close to becoming the first to be made available as part of the UK’s innovative subscription-style payment model after NICE today (Tuesday, 12 April 2022) published draft guidance estimating their value to the NHS.
NICE recommends 3 treatments for COVID-19 in final draft guidance
Everyone with COVID-19 at highest risk of developing severe disease will have access to clinically and cost-effective treatments, under final draft guidance published by NICE today.
NICE local formularies guide will 'reduce variation in prescribing'
NICE has produced a good practice guide to help trusts develop and update local formularies, as part of a move to ensure that all patients in England have access to clinically and cost-effective drugs.
NICE proposes simplifying how medicines and medical devices are selected for evaluation.
As part of the work underway to review the methods and processes NICE uses to develop guidance on medicines, medical devices and diagnostics, NICE has launched a public consultation on proposals for changing how it selects the topics it will develop guidance on.
NICE has today (25 February 2021) issued draft guidance for public consultation which recommends sapropterin (also called Kuvan and made by BioMarin) for treating phenylketonuria (PKU) in children aged up to 18.
NICE seeks to support new mothers with mental health problems
NICE is calling on general practice staff to assess the mental health of all women who have recently given birth, as fears some may be left unsupported.
NICE's methods of technology evaluation - presenting a case for change
NICE has today (6 November 2020) launched a public consultation on proposals for changes to the methods it uses to develop its guidance on medicines, medical devices and diagnostics.